Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
10 2020
Historique:
received: 24 10 2019
accepted: 18 03 2020
revised: 27 02 2020
pubmed: 5 5 2020
medline: 3 7 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

Preparing children with chronic kidney disease (CKD) for renal replacement therapy (RRT) begins with a discussion about transplant and dialysis, but its typical timing in the course of CKD management is unclear. We aimed to describe participant-reported RRT planning discussions by CKD stage, clinical and sociodemographic characteristics, in the Chronic Kidney Disease in Children (CKiD) cohort. Participants responded to the question "In the past year, have you discussed renal replacement therapy with your doctor or healthcare provider?" at annual study visits. Responses were linked to the previous year CKD risk stage based on GFR and proteinuria. Repeated measure logistic models estimated the proportion discussing RRT by stage, with modification by sex, age, race, socioeconomic status, and CKD diagnosis (glomerular vs. non-glomerular). A total of 721 CKiD participants (median age = 12, 62% boys) contributed 2856 person-visits. Proportions of person-visits reporting RRT discussions increased as CKD severity increased (10% at the lowest disease stage and 87% at the highest disease stage). After controlling for CKD risk stage, rates of RRT discussions did not differ by sex, age, race, and socioeconomic status. Despite participant-reported RRT discussions being strongly associated with CKD severity, a substantial proportion with advanced CKD reported no discussion. While recall bias may lead to underreporting, it is still meaningful that some participants with severe CKD did not report or remember discussing RRT. Initiating RRT discussions early in the CKD course should be encouraged to foster comprehensive preparation and to align RRT selection for optimal health and patient preferences.

Sections du résumé

BACKGROUND
Preparing children with chronic kidney disease (CKD) for renal replacement therapy (RRT) begins with a discussion about transplant and dialysis, but its typical timing in the course of CKD management is unclear. We aimed to describe participant-reported RRT planning discussions by CKD stage, clinical and sociodemographic characteristics, in the Chronic Kidney Disease in Children (CKiD) cohort.
METHODS
Participants responded to the question "In the past year, have you discussed renal replacement therapy with your doctor or healthcare provider?" at annual study visits. Responses were linked to the previous year CKD risk stage based on GFR and proteinuria. Repeated measure logistic models estimated the proportion discussing RRT by stage, with modification by sex, age, race, socioeconomic status, and CKD diagnosis (glomerular vs. non-glomerular).
RESULTS
A total of 721 CKiD participants (median age = 12, 62% boys) contributed 2856 person-visits. Proportions of person-visits reporting RRT discussions increased as CKD severity increased (10% at the lowest disease stage and 87% at the highest disease stage). After controlling for CKD risk stage, rates of RRT discussions did not differ by sex, age, race, and socioeconomic status.
CONCLUSIONS
Despite participant-reported RRT discussions being strongly associated with CKD severity, a substantial proportion with advanced CKD reported no discussion. While recall bias may lead to underreporting, it is still meaningful that some participants with severe CKD did not report or remember discussing RRT. Initiating RRT discussions early in the CKD course should be encouraged to foster comprehensive preparation and to align RRT selection for optimal health and patient preferences.

Identifiants

pubmed: 32363486
doi: 10.1007/s00467-020-04542-2
pii: 10.1007/s00467-020-04542-2
pmc: PMC8989139
mid: NIHMS1785988
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1925-1933

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK066143
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK066174
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24-DK-66116
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01-DK-66143
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK066116
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01-DK-66174
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK082194
Pays : United States

Références

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2063-2065
pubmed: 29162594
Kidney Int. 2008 Nov;74(9):1178-84
pubmed: 18668024
Am J Kidney Dis. 2013 Dec;62(6):1087-94
pubmed: 23932090
Ann Epidemiol. 2016 Nov;26(11):780-787.e1
pubmed: 27789133
Am J Kidney Dis. 2019 Feb;73(2):156-162
pubmed: 30318132
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):694-703
pubmed: 26536899
Pediatr Nephrol. 2016 Oct;31(10):1579-91
pubmed: 26310616
Clin J Am Soc Nephrol. 2009 Aug;4(8):1363-9
pubmed: 19556378
Pediatr Clin North Am. 2010 Apr;57(2):393-400, table of contents
pubmed: 20371043
Kidney Int. 2018 Jul;94(1):170-177
pubmed: 29735307
Pediatr Nephrol. 2012 May;27(5):835-41
pubmed: 22105968
Kidney Int. 2005 Oct;68(4):1777-83
pubmed: 16164654
Kidney Int. 2016 Nov;90(5):1100-1108
pubmed: 27653837
J Clin Endocrinol Metab. 2008 Apr;93(4):1359-65
pubmed: 18198222
Am J Epidemiol. 2011 Sep 1;174(5):604-12
pubmed: 21828368
Clin J Am Soc Nephrol. 2006 Sep;1(5):1006-15
pubmed: 17699320
J Am Soc Nephrol. 2014 Dec;25(12):2871-7
pubmed: 25168028
Am J Kidney Dis. 2015 Jun;65(6):878-88
pubmed: 25799137
Pediatr Nephrol. 2007 Dec;22(12):1999-2009
pubmed: 17310363
J Adv Nurs. 1999 Apr;29(4):869-76
pubmed: 10215978
Pediatr Nephrol. 2018 Oct;33(10):1759-1764
pubmed: 29948310
Am J Kidney Dis. 2018 Jun;71(6):783-792
pubmed: 29653769
Am J Transplant. 2006;6(5 Pt 2):1132-52
pubmed: 16613592

Auteurs

Derek K Ng (DK)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. dng@jhu.edu.

Yunwen Xu (Y)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Julien Hogan (J)

Emory Transplant Center, Department of Surgery, Emory School of Medicine, Atlanta, GA, USA.

Jeffrey M Saland (JM)

Department of Pediatrics, Kravis Children's Hospital, the Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Larry A Greenbaum (LA)

Department of Pediatrics, Emory School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Susan L Furth (SL)

Department of Pediatrics, Division of Nephrology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Bradley A Warady (BA)

Department of Pediatrics, Division of Nephrology, Children's Mercy Kansas City, Kansas City, MO, USA.

Craig S Wong (CS)

Department of Pediatrics, Division of Nephrology, University of New Mexico Children's Hospital, Albuquerque, NM, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH